Glucosio Monico

Glucosio Monico is a pharmaceutical product that contains glucose monohydrate as its sole active ingredient, supplied as an intravenous solution for injection. Marketed in the European Union and available by prescription, it is formulated to deliver a sterile, isotonic glucose solution for clinical use. The preparation is used primarily in settings that require rapid provision of carbohydrate energy and fluid replacement and electrolyte balance during treatment.

Glucosio Monico is indicated for several clinical situations where rapid carbohydrate delivery and fluid support are required.

- Treatment of hypoglycemia when oral glucose is not feasible. - Provision of calories in parenteral nutrition regimens. - Fluid replacement in patients with dehydration or electrolyte loss. - Support during perioperative care to maintain blood glucose levels. - Management of electrolyte disturbances when combined with appropriate salts.

Adverse reactions to Glucosio Monico are generally related to the intravenous administration of a glucose solution.

Common: - Mild hyperglycemia - Local irritation at the injection site - Nausea or vomiting - Transient headache

Serious: - Severe hyperglycemia leading to osmotic diuresis - Allergic reactions such as rash, urticaria, or anaphylaxis - Electrolyte imbalance, particularly hyponatremia - Volume overload in patients with cardiac or renal impairment

When prescribing Glucosio Monico, clinicians should consider several safety precautions to minimize risks.

- Assess baseline blood glucose and monitor levels during infusion. - Adjust infusion rate in patients with diabetes or impaired glucose tolerance. - Use caution in individuals with renal or cardiac failure due to risk of fluid overload. - Verify compatibility with other intravenous solutions before mixing. - Avoid rapid administration in neonates and infants. - Review electrolyte status, especially sodium and potassium, prior to therapy. - Document any prior hypersensitivity to glucose solutions.

Glucosio Monico may interact with other medications or solutions administered intravenously.

Avoid: - Concurrent infusion of high‑concentration dextrose solutions that could cause hyperosmolarity. - Co‑administration with insulin bolus doses without appropriate glucose monitoring. - Mixing with calcium‑containing solutions that may precipitate.

Use with caution: - Concurrent use of diuretics, which may alter fluid balance. - Administration alongside beta‑blockers, which can mask hypoglycemia symptoms. - Use with electrolyte‑replacing agents; monitor serum levels closely. - Combination with other carbohydrate‑containing parenterals; adjust total glucose load.